Correlation
The correlation between TMDX and LLY is 0.38, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
TMDX vs. LLY
Compare and contrast key facts about TransMedics Group, Inc. (TMDX) and Eli Lilly and Company (LLY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: TMDX or LLY.
Performance
TMDX vs. LLY - Performance Comparison
Loading data...
Key characteristics
TMDX:
-0.10
LLY:
-0.23
TMDX:
0.26
LLY:
-0.04
TMDX:
1.04
LLY:
0.99
TMDX:
-0.16
LLY:
-0.32
TMDX:
-0.25
LLY:
-0.59
TMDX:
43.39%
LLY:
13.61%
TMDX:
69.15%
LLY:
38.49%
TMDX:
-73.69%
LLY:
-68.27%
TMDX:
-27.82%
LLY:
-22.74%
Fundamentals
TMDX:
$4.33B
LLY:
$662.23B
TMDX:
$1.41
LLY:
$12.54
TMDX:
90.16
LLY:
58.83
TMDX:
8.86
LLY:
13.51
TMDX:
16.22
LLY:
42.01
TMDX:
$488.23M
LLY:
$49.00B
TMDX:
$290.25M
LLY:
$40.03B
TMDX:
$82.66M
LLY:
$16.27B
Returns By Period
In the year-to-date period, TMDX achieves a 103.88% return, which is significantly higher than LLY's -4.09% return.
TMDX
103.88%
40.54%
46.60%
-6.80%
63.34%
57.28%
N/A
LLY
-4.09%
-6.92%
-6.90%
-9.46%
34.17%
38.59%
27.48%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
TMDX vs. LLY — Risk-Adjusted Performance Rank
TMDX
LLY
TMDX vs. LLY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for TransMedics Group, Inc. (TMDX) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
TMDX vs. LLY - Dividend Comparison
TMDX has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.76%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
TMDX TransMedics Group, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LLY Eli Lilly and Company | 0.76% | 0.67% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.95% | 2.46% | 2.77% | 2.37% | 2.84% |
Drawdowns
TMDX vs. LLY - Drawdown Comparison
The maximum TMDX drawdown since its inception was -73.69%, which is greater than LLY's maximum drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for TMDX and LLY.
Loading data...
Volatility
TMDX vs. LLY - Volatility Comparison
TransMedics Group, Inc. (TMDX) has a higher volatility of 19.77% compared to Eli Lilly and Company (LLY) at 16.63%. This indicates that TMDX's price experiences larger fluctuations and is considered to be riskier than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
TMDX vs. LLY - Financials Comparison
This section allows you to compare key financial metrics between TransMedics Group, Inc. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TMDX vs. LLY - Profitability Comparison
TMDX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, TransMedics Group, Inc. reported a gross profit of 88.23M and revenue of 143.54M. Therefore, the gross margin over that period was 61.5%.
LLY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Eli Lilly and Company reported a gross profit of 10.50B and revenue of 12.73B. Therefore, the gross margin over that period was 82.5%.
TMDX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, TransMedics Group, Inc. reported an operating income of 27.44M and revenue of 143.54M, resulting in an operating margin of 19.1%.
LLY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Eli Lilly and Company reported an operating income of 5.41B and revenue of 12.73B, resulting in an operating margin of 42.5%.
TMDX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, TransMedics Group, Inc. reported a net income of 25.68M and revenue of 143.54M, resulting in a net margin of 17.9%.
LLY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Eli Lilly and Company reported a net income of 2.76B and revenue of 12.73B, resulting in a net margin of 21.7%.